Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Recursion Pharmaceuticals Inc (RXRX) – Recursion Pharmaceuticals Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Recursion Pharmaceuticals (RXRX) trades at $2.93, down 3.62% on the day, reflecting ongoing investor concerns despite recent earnings beats. The stock shows a bearish technical signal with oversold short-term RSI readings. Fundamentally, the company operates at significant losses with a -851.51% net income margin, though it maintains a strong cash position from financing activities. Recent news highlights clinical progress with REC-4881 and participation in major healthcare conferences.
The outlook remains speculative with high execution risk. Investment opportunity centers on the company's AI-driven drug discovery platform and pipeline potential, particularly REC-4881 for FAP. Primary risks include sustained cash burn, revenue decline, and competitive pressures in biotech AI. Analyst consensus is cautiously optimistic with a $7.38 price target, though technical indicators suggest near-term weakness.
Read full analysis

Key Stats

  • Market Cap
    $1.55B
  • Sector
    Health
  • 3M Drawdown
    -24.67%
  • Enterprise Value
    $970.38M
  • Dividend Yield
    -
  • Trading Activity
    98% Buy | 2% Sell
  • Typical Hold Time
    13 days
$2.89
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.55B, with an enterprise value of $970.38M. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -24.67%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 13 days, indicating typical investor behavior on the platform.

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.55B
  • Sector
    Health
  • 3M Drawdown
    -24.67%
  • Enterprise Value
    $970.38M
  • Dividend Yield
    -
  • Trading Activity
    98% Buy | 2% Sell
  • Typical Hold Time
    13 days
$2.89
52W Low: $2.84
30 Mar 2026
52W High: $6.79
15 Oct 2025

Recursion Pharmaceuticals Inc (RXRX) is currently valued at a market capitalization of $1.55B, with an enterprise value of $970.38M. Over the past 52 weeks, Recursion Pharmaceuticals Inc has traded between a low of $2.84 and a high of $6.79, highlighting its annual price range. Over the past three months, Recursion Pharmaceuticals Inc has recorded a drawdown of -24.67%, reflecting recent price volatility. On average, investors hold Recursion Pharmaceuticals Inc for approximately 13 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!